TCCPY yields 2.09% · PFE yields 6.20%● Live data
📍 TCCPY pulled ahead of the other in Year 1
Combined, TCCPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCCPY + PFE for your $10,000?
TechnoPro Holdings, Inc., through its subsidiaries, operates as a technology-focused staffing and services company in Japan and internationally. The company offers various services, including engineer staffing, contract assignment, engineering consulting, domestic nearshore and overseas offshore delivery, job placement, and education and training in the machinery, electrics and electronics, embedded controls, information systems, IT infrastructure, software development and maintenance, civil engineering, production plant, architecture, chemistry, biotechnology, and construction areas. It also provides IT system integration and package products; application development and IT consulting services; assessment, inspection, design, and supervision services of buildings; employment services for people with disabilities; and education and training services for CAD, programming, network construction, web design, PC operation, Microsoft office, etc. In addition, the company offers engineering consultancy and offshore development services; and recruitment process outsourcing services, as well as operates as a recruitment agency. TechnoPro Holdings, Inc. was formerly known as Prompt Holdings, Inc. and changed its name to TechnoPro Holdings, Inc. in April 2013. The company was founded in 1995 and is headquartered in Tokyo, Japan.
Full TCCPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.